-
American Airlines swings to a loss, but tops estimates for Q2 forecast
American Airlines swung to a loss in the first quarter. Its forecast for the current period surpassed analysts’ estimates. American Airlines swung to a loss in the first quarter but its forecast for the current period surpassed analysts’ estimates, sending shares roughly 4% higher. American expects to earn between $1.15 and $1.45 per share in the second quarter, on an…
-
Harvard nutritionist: The No. 1 nutrient you need for a healthy brain—and the best way to get it
There’s no one-size-fits-all way to prevent dementia, but a key nutrient found in salmon, sesame seeds, walnuts, and more can help keep your brain sharp as you age.
-
Harvard career advisor: Use these 10 phrases every day to stand out and succeed at work
“What you say and how you say it can determine how people at work perceive you and where you end up,” says Gorick Ng, a career adviser at Harvard University.
-
5 things to know before the stock market opens Thursday
Here are the most important news items that investors need to start their trading day.
-
Supreme Court to decide if Trump is immune from prosecution in election interference case
The Supreme Court will hear oral arguments today over whether Donald Trump is immune from prosecution in a case charging him with plotting to overturn the results of the 2020 presidential election.
-
Red Lobster seeks a buyer as it looks to avoid bankruptcy filing
Beleaguered seafood chain Red Lobster is looking for a buyer to avoid filing for bankruptcy as it contends with slower sales and costly leases.
-
Venice residents clash with riot police as city launches world's first tourist entry fee
The pilot program means day-trippers to Venice, one of Italy’s most picturesque and historic cities, will need to pay a charge of 5 euros ($5.4).
-
Southwest cuts growth plans, warning impact of Boeing airplane delays will last into 2025
Southwest Airlines is one of Boeing’s biggest customers and flies only 737s.
-
Chicago Bears 2024 NFL Draft Guide: Picks, prospects, rumors and more
Day one of the 2024 NFL Draft is officially here, and with the No. 1 pick in tow, all eyes are on the Chicago Bears.
-
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
The first-quarter results come as Merck shows substantial progress in preparing for Keytruda’s patent expiration in 2028.
Recent stories, 1,000 results.